• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

States move forward with unique ACO models for Medicaid


Early efforts by states drive value with Medicaid ACOs, coordinated care.

Key Points

HEALTHCARE'S DIFFICULT times call for bold steps in value strategies, such as patient-centered medical homes, shared-savings and others.

In addition to the five states that are moving forward on Medicaid ACOs-Colorado, Minnesota, New Jersey, Oregon and Utah-another five could commit within the next six months, says Tricia McGinnis, senior program officer at the Center for Health Care Strategies (CHCS). The not-for-profit health policy resource center works with state and federal agencies to improve the quality of Medicaid programs and currently is working with 39 states.

"Data is a huge component of success," McGinnis says. "Providers often don't have that line of sight into the care they deliver that good data can bring."

Four out of five also have an active managed-care organization in the mix, according to CHCS research by McGinnis and policy analyst David Marc Small. Colorado and Oregon are developing hybrid payer/provider-led programs, while Minnesota has a combination of governance. Utah is exploring the payer-led model for its program in four populous counties around Salt Lake City.

Related Content
© 2023 MJH Life Sciences

All rights reserved.